Seeking Alpha
 

Monsanto Company (MON)

- NYSE
Show Summaries  |  Hide Summaries
  • Apr. 3, 2013, 2:16 PM
    From Monsanto's (MON +0.3%) conference call: If MON achieves the higher profit it is targeting, it will mark the third straight year of better than 20% EPS growth, Chairman Hugh Grant says. But the market reaction is only mildly enthusiastic since gains that beat analysts' expectations stemmed not from seed sales but from the smaller glyphosate herbicide business, and from a lower tax rate.
    | Comment!
  • Apr. 3, 2013, 8:28 AM
    More on Monsanto's (MON) FQ2 results: Raises FY 2013 EPS guidance to $4.40-$4.50 vs. $4.54 consensus and prior guidance of $4.30-$4.40. Net sales rose 15% to $5.5B, driven by a 16% increase in sales from its global corn business. Sales in seeds and genomics totaled $4.3B, $422M more than the same period last year. Shares +1% premarket.
    | 2 Comments
  • Apr. 3, 2013, 8:03 AM
    Monsanto (MON): FQ2 EPS of $2.73 beats by $0.17. Revenue of $5.47B beats by $0.18B. (PR)
    | 1 Comment
  • Apr. 3, 2013, 12:05 AM
    Notable earnings before Wednesday’s open: CAG, MON, SCHN
    | Comment!
  • Apr. 2, 2013, 5:30 PM
    Notable earnings before Wednesday’s open: CAG, MON, SCHN
    | Comment!
  • Mar. 26, 2013, 12:21 PM
    Shares of Monsanto (MON +3.7%) and DuPont (DD -1%) react differently to news the companies settled a patent dispute over technology rights for genetically modified seeds. The deal tosses out a $1B jury verdict DD was ordered to pay MON last year; instead, DD will make at least $1.75B in royalty payments over several years in return for broad access to develop products using MON's genetic technology.
    | Comment!
  • Mar. 15, 2013, 7:05 PM
    Morgan Stanley selects 20 stocks for the long term, based on "competitive advantages, business model, pricing power, cost efficiency and growth": AMZN, AMT, BLK, CPN, CP, CVX, COST, EL, GILD, HON, JPM, LTD, MON, NWSA, PM, RPM, SBUX, SYMC, TMO, WMB.
    | 13 Comments
  • Mar. 6, 2013, 9:15 AM
    Monsanto (MON) awards a potentially lucrative contract to distribute its crop protection products in Australia and New Zealand to China's Sinochem, a day after terminating a decade-long deal with Nufarm (NUFMF.PK). Sinochem already sells MON's Roundup brand in China and the Philippines. Meanwhile, the Australian pesticide and herbicide producer may have become an M&A target.
    | Comment!
  • Feb. 19, 2013, 6:23 PM
    Based on today's questioning by Supreme Court justices, Monsanto (MON) looks to be in a strong position to claim that an Indiana farmer violated its patent for a type of soybean. "There are certain things the law prohibits," Justice Breyer told the farmer's lawyer in the closely watched case. "What it prohibits here is making a copy of the patented invention. And that is what he did."
    | 6 Comments
  • Feb. 15, 2013, 9:47 AM
    A dispute between an Indiana farmer and Monsanto (MON) over soybean seeds will be heard next week at the Supreme Court. At issue is how long MON can claim patent protection for its genetically engineered seeds, but it isn't just the agriculture world that's nervous about the outcome. Microsoft (MSFT) and Apple (AAPL) have filed briefs saying a ruling against MON would "eviscerate" their patent protection.
    | 20 Comments
  • Jan. 31, 2013, 5:53 PM
    Monsanto Company (MON) declares $0.375/share quarterly dividend, in line with previous. Forward yield 1.48%. For shareholders of record Apr. 05. Payable Apr. 26. Ex-div date Apr. 03. (PR)
    | Comment!
  • Jan. 23, 2013, 6:12 PM
    Monsanto (MON) agreed to waive two years of royalties on its Roundup Ready soybean seeds for Brazilian farmers who agree to forgo claims in a patent dispute. The agreement would resolve claims by growers who claim the patent expired in 2010, ending their obligation to pay royalties on the seeds, and helps resolve uncertainty about MON’s ability to collect fees on its new Intacta soybean.
    | Comment!
  • Jan. 18, 2013, 3:13 PM
    Dow Chemical's (DOW -0.3%) controversial new Enlist biotech corn will be delayed at least another year as the company awaits regulatory approval amid opposition from farmers, consumers and public health officials. Dow aims for Enlist eventually to replace Monsanto's (MON +0.6%) market-leading Roundup Ready system.
    | 1 Comment
  • Jan. 17, 2013, 10:58 AM
    Initiating coverage on the "North American Agricultural Sciences" sector, Credit Suisse declares itself a fan of some, with Agrium (AGU), Monsanto (MON), and Potash (POT) all rated Buys. MOS, CF, and IPI are rated Neutral, with Compass Minerals (CMP) started at Sell on worries over the implementation of cost-cutting. All of these companies are holdings of MOO, +4,5% YTD.
    | Comment!
  • Jan. 8, 2013, 3:18 PM
    Monsanto's (MON +2.6%) improved profit forecast for the year, by $100M to $7.65B, reflects a gain of $200M-$300M despite deciding to omit profit from Roundup Ready soybeans in Brazil because of the legal dispute over patent expiration, CFO Pierre Courduroux said on today's conference call. MON may be more aggressive in returning cash to shareholders, CEO Hugh Grant added.
    | Comment!
  • Jan. 8, 2013, 8:28 AM
    More on Monsanto's (MON) FQ1 results: Seeds and genomics sales rose 14% to $1.8B, with corn seed and traits net sales up 27% Y/Y to $1.1B, driven by strength in Brazil, Argentina and Mexico. Raises FY13 EPS guidance to $4.30-$4.40 vs. prior $4.18-$4.32 and $4.40 consensus. Raises FY13 free cash flow guidance to $1.8B-$2B. Shares look headed to new 52-week highs, +4.7% premarket.
    | 3 Comments
Visit Seeking Alpha's
MON vs. ETF Alternatives
Company Description
Monsanto Co is a provider of agricultural products for farmers. The Company offers corn, soybean, cotton, wheat, canola, sorghum and sugar cane seeds. Its segments are Seeds and Genomics and Agricultural Productivity.